Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Dec 28;28(4):605–613. doi: 10.1200/JCO.2009.23.4781

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2009 by American Society of Clinical Oncology

PMC Copyright notice

Fig 1. — Kaplan-Meier survival estimates of overall and progression-free survival in patients with myelodysplastic syndromes. Overall survival in (A) training cohort, (B) first validation cohort, (C) second validation cohort, and (D) all patients. Progression-free survival in (E) training cohort, (F) first validation cohort, (G) second validation cohort, and (H) all patients. In each panel, patients are grouped into methylation low (gold) or methylation high (blue) groups according to their combined methylation z scores. Median survival (95% CI) of each group in each panel is shown. P values are based on the log-rank test.